VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VYNE VYNE Therapeutics Inc.

交易中 12-15 10:38:18 EST

0.3664

-0.0092

-2.45%

最高0.3751	最低0.3615	成交量22.66万
今开0.3744	昨收0.3756	日振幅3.62%
总市值1,220万	流通市值1,129万	总股本3,329万
成交额8.33万	换手率0.74%	流通股本3,082万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":0.3664,"timestamp":1765813059285,"preClose":0.3756,"halted":0,"volume":226588,"delay":0,"floatShares":30823100,"shares":33286422,"eps":-0.788408,"marketStatus":"交易中","change":-0.0092,"latestTime":"12-15 10:38:18 EST","open":0.3744,"high":0.3751,"low":0.3615,"amount":83281.88918408,"amplitude":0.036209,"askPrice":0.3683,"askSize":701,"bidPrice":0.3644,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.788408,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":0.3756,"preHourTrading":{"tag":"盘前","latestPrice":0.371,"preClose":0.3756,"latestTime":"09:03 EST","volume":26562,"amount":10012.64471064,"timestamp":1765807429814},"postHourTrading":{"tag":"盘后","latestPrice":0.3751,"preClose":0.3756,"latestTime":"16:41 EST","volume":13704,"amount":5232.7076,"timestamp":1765575689350},"volumeRatio":1.2369,"impliedVol":3.8705,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VYNE","defaultTab":"news","newsList":[{"id":"1188319037","title":"VYNE Therapeutics 第三季度收入为 16.9 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188319037","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188319037?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:59","pubTimestamp":1763571588,"startTime":"0","endTime":"0","summary":"11月6日——VYNE Therapeutics 第三季度净收入为 -728 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2581090553","title":"Vyne Therapeutics Inc.盘中异动 急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581090553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581090553?lang=zh_cn&edition=full","pubTime":"2025-11-06 01:22","pubTimestamp":1762363365,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日01时22分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨5.31%。截至发稿，该股报0.345美元/股，成交量29.2393万股，换手率1.15%，振幅6.11%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110601224697563c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110601224697563c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2558650945","title":"Vyne Therapeutics Inc.8月8日成交额为96.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558650945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558650945?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:14","pubTimestamp":1754727273,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Vyne Therapeutics Inc.成交额为96.19万美元，成交额较昨日减少45.20%，当日成交量为271.51万股。Vyne Therapeutics Inc.于2025年8月8日跌5.36%，报0.357美元，该股过去5个交易日涨1.1%，年初至今跌89.35%，过去60日跌72.76%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|96.19万|-45.20%|271.51万|#|2025-08-07|175.54万|64.64%|467.26万|#|2025-08-06|106.62万|-41.00%|294.79万|#|2025-08-05|180.73万|24.73%|483.15万|#|2025-08-04|144.90万|38.11%|409.39万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809161436a6dc4b17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809161436a6dc4b17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VYNE","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2557427215","title":"Vyne Therapeutics Inc.8月7日成交额为175.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557427215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557427215?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:11","pubTimestamp":1754640694,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Vyne Therapeutics Inc.成交额为175.54万美元，成交额较昨日增加64.64%，当日成交量为467.26万股。Vyne Therapeutics Inc.于2025年8月7日涨3.32%，报0.377美元，该股过去5个交易日涨3.03%，年初至今跌88.74%，过去60日跌69.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|175.54万|64.64%|467.26万|#|2025-08-06|106.62万|-41.00%|294.79万|#|2025-08-05|180.73万|24.73%|483.15万|#|2025-08-04|144.90万|38.11%|409.39万|#|2025-08-01|104.92万|-56.73%|295.77万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808172725a47cf234&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808172725a47cf234&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VYNE","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2557553896","title":"Vyne Therapeutics Inc.8月6日成交额为106.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557553896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557553896?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:04","pubTimestamp":1754553861,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Vyne Therapeutics Inc.成交额为106.62万美元，成交额较昨日减少41.00%，当日成交量为294.79万股。Vyne Therapeutics Inc.于2025年8月6日涨1.36%，报0.365美元，该股过去5个交易日跌8.29%，年初至今跌89.1%，过去60日跌71.92%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|106.62万|-41.00%|294.79万|#|2025-08-05|180.73万|24.73%|483.15万|#|2025-08-04|144.90万|38.11%|409.39万|#|2025-08-01|104.92万|-56.73%|295.77万|#|2025-07-31|242.45万|-84.05%|645.29万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807164949a47a86fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807164949a47a86fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","VYNE","LENZ"],"gpt_icon":0},{"id":"2557321001","title":"Vyne Therapeutics Inc.8月5日成交额为180.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557321001","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557321001?lang=zh_cn&edition=full","pubTime":"2025-08-06 15:54","pubTimestamp":1754466898,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Vyne Therapeutics Inc.成交额为180.73万美元，成交额较昨日增加24.73%，当日成交量为483.15万股。Vyne Therapeutics Inc.于2025年8月5日跌1.4%，报0.36美元，该股过去5个交易日跌74.99%，年初至今跌89.25%，过去60日跌72.3%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|180.73万|24.73%|483.15万|#|2025-08-04|144.90万|38.11%|409.39万|#|2025-08-01|104.92万|-56.73%|295.77万|#|2025-07-31|242.45万|-84.05%|645.29万|#|2025-07-30|1520.28万|3531.14%|3845.10万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806162513a47845f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806162513a47845f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VYNE","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2557916366","title":"Vyne Therapeutics Inc.8月4日成交额为144.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557916366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557916366?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:52","pubTimestamp":1754380362,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Vyne Therapeutics Inc.成交额为144.90万美元，成交额较昨日增加38.11%，当日成交量为409.39万股。Vyne Therapeutics Inc.于2025年8月4日涨3.49%，报0.365美元，该股过去5个交易日跌74.81%，年初至今跌89.1%，过去60日跌73.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|144.90万|38.11%|409.39万|#|2025-08-01|104.92万|-56.73%|295.77万|#|2025-07-31|242.45万|-84.05%|645.29万|#|2025-07-30|1520.28万|3531.14%|3845.10万|#|2025-07-29|41.87万|-56.69%|29.20万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805161309a6d40d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805161309a6d40d95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2553720552","title":"Vyne Therapeutics Inc.7月23日成交额为267.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553720552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553720552?lang=zh_cn&edition=full","pubTime":"2025-07-24 15:38","pubTimestamp":1753342694,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Vyne Therapeutics Inc.成交额为267.30万美元，成交额较昨日增加328.14%，当日成交量为197.37万股。Vyne Therapeutics Inc.于2025年7月23日涨29.46%，报1.45美元，该股过去5个交易日涨15.08%，年初至今跌56.72%，过去60日涨1.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|267.30万|328.14%|197.37万|#|2025-07-22|62.43万|-50.90%|54.15万|#|2025-07-21|127.16万|43.41%|108.21万|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155115a460c47c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155115a460c47c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2553218606","title":"Vyne Therapeutics Inc.7月22日成交额为62.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553218606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553218606?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:36","pubTimestamp":1753256186,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Vyne Therapeutics Inc.成交额为62.43万美元，成交额较昨日减少50.90%，当日成交量为54.15万股。Vyne Therapeutics Inc.于2025年7月22日跌7.44%，报1.12美元，该股过去5个交易日跌13.18%，年初至今跌66.57%，过去60日跌40.43%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-22|62.43万|-50.90%|54.15万|#|2025-07-21|127.16万|43.41%|108.21万|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723154915a45e44fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723154915a45e44fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","VYNE","BK4139"],"gpt_icon":0},{"id":"2553871082","title":"Vyne Therapeutics Inc.7月21日成交额为127.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553871082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553871082?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:21","pubTimestamp":1753168898,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Vyne Therapeutics Inc.成交额为127.16万美元，成交额较昨日增加43.41%，当日成交量为108.21万股。Vyne Therapeutics Inc.于2025年7月21日涨4.31%，报1.21美元，该股过去5个交易日跌9.02%，年初至今跌63.88%，过去60日跌34.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-21|127.16万|43.41%|108.21万|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|#|2025-07-15|34.97万|-59.49%|26.58万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722152404a45b9d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722152404a45b9d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","VYNE","LENZ"],"gpt_icon":0},{"id":"2552341994","title":"Vyne Therapeutics Inc.7月18日成交额为88.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552341994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552341994?lang=zh_cn&edition=full","pubTime":"2025-07-19 14:57","pubTimestamp":1752908222,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，Vyne Therapeutics Inc.成交额为88.67万美元，成交额较昨日增加44.95%，当日成交量为75.49万股。Vyne Therapeutics Inc.于2025年7月18日跌3.33%，报1.16美元，该股过去5个交易日跌18.31%，年初至今跌65.37%，过去60日跌37.63%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|#|2025-07-15|34.97万|-59.49%|26.58万|#|2025-07-14|86.33万|-8.30%|64.50万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145705a6b388df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145705a6b388df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYNE","BK4007","BK4539"],"gpt_icon":0},{"id":"2552010155","title":"Vyne Therapeutics Inc.7月16日成交额为37.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552010155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552010155?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:36","pubTimestamp":1752737784,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Vyne Therapeutics Inc.成交额为37.42万美元，成交额较昨日增加7.01%，当日成交量为29.24万股。Vyne Therapeutics Inc.于2025年7月16日跌2.33%，报1.26美元，该股过去5个交易日跌12.5%，年初至今跌62.39%，过去60日跌31.89%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|37.42万|7.01%|29.24万|#|2025-07-15|34.97万|-59.49%|26.58万|#|2025-07-14|86.33万|-8.30%|64.50万|#|2025-07-11|94.14万|70.40%|67.11万|#|2025-07-10|55.25万|-4.00%|39.21万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717155010a6af34ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717155010a6af34ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","VYNE","BK4139"],"gpt_icon":0},{"id":"2549626555","title":"Vyne Therapeutics Inc.盘中异动 大幅跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549626555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549626555?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:17","pubTimestamp":1751897840,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时17分，Vyne Therapeutics Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报1.35美元/股，成交量15.3799万股，换手率0.92%，振幅5.92%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707221721979d21c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707221721979d21c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BK4007","VYNE"],"gpt_icon":0},{"id":"2548876533","title":"Vyne Therapeutics Inc.7月2日成交额为416.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548876533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548876533?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:23","pubTimestamp":1751527437,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Vyne Therapeutics Inc.成交额为416.95万美元，成交额较昨日增加21.28%，当日成交量为263.88万股。Vyne Therapeutics Inc.于2025年7月2日跌14.69%，报1.51美元，该股过去5个交易日涨10.22%，年初至今跌54.93%，过去60日跌3.21%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|416.95万|21.28%|263.88万|#|2025-07-01|343.79万|103.27%|188.80万|#|2025-06-30|169.13万|-10.91%|106.36万|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2548586189","title":"Vyne Therapeutics Inc.7月1日成交额为343.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548586189","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548586189?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:09","pubTimestamp":1751440177,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Vyne Therapeutics Inc.成交额为343.79万美元，成交额较昨日增加103.27%，当日成交量为188.80万股。Vyne Therapeutics Inc.于2025年7月1日涨7.27%，报1.77美元，该股过去5个交易日涨66.98%，年初至今跌47.16%，过去60日涨5.99%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|343.79万|103.27%|188.80万|#|2025-06-30|169.13万|-10.91%|106.36万|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|#|2025-06-25|1047.51万|855.99%|753.71万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702150946a4ca8cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702150946a4ca8cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VYNE","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2546615771","title":"Vyne Therapeutics Inc.6月27日成交额为189.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546615771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546615771?lang=zh_cn&edition=full","pubTime":"2025-06-28 14:56","pubTimestamp":1751093779,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Vyne Therapeutics Inc.成交额为189.83万美元，成交额较昨日减少76.67%，当日成交量为123.81万股。Vyne Therapeutics Inc.于2025年6月27日跌12.35%，报1.42美元，该股过去5个交易日涨59.55%，年初至今跌57.61%，过去60日跌7.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|#|2025-06-25|1047.51万|855.99%|753.71万|#|2025-06-24|109.57万|661.07%|110.01万|#|2025-06-23|14.40万|-61.67%|15.89万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628145620a4c2995b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628145620a4c2995b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","VYNE","BK4539","LENZ"],"gpt_icon":0},{"id":"2546450502","title":"Vyne Therapeutics Inc.盘中异动 股价大涨5.16%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546450502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546450502?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:38","pubTimestamp":1750858706,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时38分，Vyne Therapeutics Inc.股票出现异动，股价快速上涨5.16%。截至发稿，该股报1.11美元/股，成交量8.7063万股，换手率0.52%，振幅3.27%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Plus Therapeutics, Inc.、Nutriband Inc C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Plus Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Portage Biotech Inc.较为活跃，换手率分别为659.87%、199.78%、143.75%，振幅较大的相关个股有Plus Therapeutics, Inc.、180 Life Sciences Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为34.55%、18.10%、15.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213826952b3bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213826952b3bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","VYNE"],"gpt_icon":0},{"id":"2545117779","title":"Vyne Therapeutics Inc.盘中异动 临近收盘股价大跌8.34%报0.862美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545117779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545117779?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:42","pubTimestamp":1750448546,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时42分，Vyne Therapeutics Inc.股票出现波动，股价大幅下跌8.34%。截至发稿，该股报0.862美元/股，成交量33.578万股，换手率2.01%，振幅7.60%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034226a7151461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034226a7151461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","BK4139","VYNE"],"gpt_icon":0},{"id":"2518744289","title":"Vyne Therapeutics Inc.2024财年实现净利润-39.81百万美元，同比减少42.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744289?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536074,"startTime":"0","endTime":"0","summary":"3月10日，Vyne Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-39.81百万美元，同比减少42.84%；其中营业收入为501000.00美元，同比增加18.16%，每股基本收益为-0.93美元。从资产负债表来看，Vyne Therapeutics Inc.总负债14.82百万美元，其中短期债务99000.00美元，资产负债比为4.52，流动比率为4.35。机构评级：截至2025年3月10日，当前有4家机构对Vyne Therapeutics Inc.目标价做出预测，其中目标均价为6.19美元，其中最低目标价为5.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000222abf17562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000222abf17562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYNE"],"gpt_icon":0},{"id":"1102225461","title":"VYNE Therapeutics 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1102225461","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102225461?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:18","pubTimestamp":1741267091,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics(LENZ) 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期。以上内容来自Benzinga Earnings专栏，原文如下：VYNE $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"VYNE Therapeutics 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vynetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0151},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.2097},{"period":"6month","weight":-0.5824},{"period":"1year","weight":-0.8435},{"period":"ytd","weight":-0.8879}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VYNE Therapeutics Inc.成立于2011年10月，是特拉华州的一家公司，名称为Tigercat Pharma，Inc.。该公司是一家临床阶段的生物制药公司，专注于开发用于治疗免疫炎症性疾病的专有、创新和差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.045848},{"month":2,"riseRate":0.375,"avgChangeRate":0.008948},{"month":3,"riseRate":0.375,"avgChangeRate":-0.004279},{"month":4,"riseRate":0.125,"avgChangeRate":-0.181549},{"month":5,"riseRate":0.5,"avgChangeRate":-0.002439},{"month":6,"riseRate":0.125,"avgChangeRate":-0.051065},{"month":7,"riseRate":0.375,"avgChangeRate":-0.153902},{"month":8,"riseRate":0.125,"avgChangeRate":-0.085706},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023153},{"month":10,"riseRate":0.5,"avgChangeRate":0.011012},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029442},{"month":12,"riseRate":0.25,"avgChangeRate":-0.095989}],"exchange":"NASDAQ","name":"VYNE Therapeutics Inc.","nameEN":"VYNE Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VYNE Therapeutics Inc.,VYNE,VYNE Therapeutics Inc.股票,VYNE Therapeutics Inc.股票老虎,VYNE Therapeutics Inc.股票老虎国际,VYNE Therapeutics Inc.行情,VYNE Therapeutics Inc.股票行情,VYNE Therapeutics Inc.股价,VYNE Therapeutics Inc.股市,VYNE Therapeutics Inc.股票价格,VYNE Therapeutics Inc.股票交易,VYNE Therapeutics Inc.股票购买,VYNE Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}